Journal Article

Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K–Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B

Abdelali Agouni, Carole Sourbier, Sabrina Danilin, Sylvie Rothhut, Véronique Lindner, Didier Jacqmin, Jean-Jacques Helwig, Hervé Lang and Thierry Massfelder

in Carcinogenesis

Volume 28, issue 9, pages 1893-1901
Published in print September 2007 | ISSN: 0143-3334
Published online April 2007 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgm106
Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K–Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

We have recently shown that parathyroid hormone-related protein (PTHrP), a cytokine-like polyprotein, is critical for human renal cell carcinoma (RCC) growth by inhibiting tumor cell apoptosis. Here, we have explored mechanisms by which PTHrP controls tumor cell survival. Using specific inhibitors of phosphoinositide 3-kinase (PI3K) and depletion of Akt kinase by RNA interference, we established that PTHrP is one of the main factor involved in the constitutive activation of this pathway in human RCC, independently of von Hippel-Lindau (VHL) tumor suppressor gene expression. Interestingly, PTHrP induced phosphorylation of Akt at S473 but had no influence on phosphorylation at T308. Through transfection with integrin-linked kinase (ILK) constructs and RNA interference, we provide evidence that ILK is involved in human RCC cell survival. PTHrP activates ILK which then acts as a phosphoinositide-dependent kinase (PDK)-2 or a facilitator protein to phosphorylate Akt at S473. Among other kinases tested, only ILK was shown to exert this function in RCC. Using specific inhibitors, western blot and transcription assay, we identified nuclear factor kappa B (NF-κB) as the downstream Akt target regulated by PTHrP. Since RCC remains refractory to current therapies, our results establish that the PI3K/ILK/Akt/NF-κB axis is a promising target for therapeutic intervention.

Journal Article.  6126 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.